Fjarde Ap-fonden’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $137M | Buy |
543,225
+10,300
| +2% | +$2.22M | 0.65% | 30 |
|
|
2026
Q1 | $116M | Buy |
532,925
+208,281
| +64% | +$46.2M | 0.63% | 26 |
|
|
2025
Q4 | $74.2M | Sell |
324,644
-8,700
| -3% | -$1.98M | 0.62% | 24 |
|
|
2025
Q3 | $77.2M | Sell |
333,344
-840
| -0.3% | -$171K | 0.67% | 25 |
|
|
2025
Q2 | $62M | Buy |
334,184
+25,400
| +8% | +$4.72M | 0.57% | 27 |
|
|
2025
Q1 | $64.7M | Sell |
308,784
-168,800
| -35% | -$32.8M | 0.78% | 24 |
|
|
2024
Q4 | $84.9M | Sell |
477,584
-3,500
| -0.7% | -$643K | 0.86% | 20 |
|
|
2024
Q3 | $95M | Buy |
+481,084
| New | +$89.8M | 0.97% | 19 |
|
|
2024
Q1 | $85.2M | Buy |
467,784
+16,365
| +4% | +$2.82M | 0.94% | 18 |
|
|
2023
Q4 | $70M | Sell |
451,419
-8,700
| -2% | -$1.27M | 0.88% | 21 |
|
|
2023
Q3 | $68.6M | Sell |
460,119
-14,400
| -3% | -$2.11M | 0.91% | 21 |
|
|
2023
Q2 | $63.9M | Buy |
474,519
+7,000
| +1% | +$1.03M | 0.78% | 24 |
|
|
2023
Q1 | $74.5M | Sell |
467,519
-6,499
| -1% | -$994K | 1.01% | 17 |
|
|
2022
Q4 | $76.6M | Buy |
474,018
+14,667
| +3% | +$2.25M | 1.09% | 16 |
|
|
2022
Q3 | $70.4M | Hold |
459,351
| – | – | 0.89% | 19 |
|
|
2022
Q2 | $70.4M | Buy |
459,351
+4,900
| +1% | +$749K | 0.89% | 19 |
|
|
2022
Q1 | $73.7M | Sell |
454,451
-10,602
| -2% | -$1.54M | 0.73% | 18 |
|
|
2021
Q4 | $63M | Sell |
465,053
-30,423
| -6% | -$3.59M | 0.56% | 31 |
|
|
2021
Q3 | $53.4M | Sell |
495,476
-6,200
| -1% | -$708K | 0.49% | 42 |
|
|
2021
Q2 | $56.5M | Sell |
501,676
-20,300
| -4% | -$2.29M | 0.52% | 35 |
|
|
2021
Q1 | $56.5M | Buy |
521,976
+3,000
| +0.6% | +$321K | 0.52% | 36 |
|
|
2020
Q4 | $55.6M | Sell |
518,976
-20,400
| -4% | -$1.96M | 0.53% | 35 |
|
|
2020
Q3 | $47.2M | Buy |
539,376
+17,700
| +3% | +$1.67M | 0.51% | 38 |
|
|
2020
Q2 | $51.2M | Buy |
521,676
+108,397
| +26% | +$9.54M | 0.64% | 32 |
|
|
2020
Q1 | $31.5M | Sell |
413,279
-22,700
| -5% | -$1.93M | 0.51% | 42 |
|
|
2019
Q4 | $38.6M | Sell |
435,979
-2,200
| -0.5% | -$183K | 0.47% | 42 |
|
|
2019
Q3 | $33.2M | Sell |
438,179
-1,757
| -0.4% | -$120K | 0.43% | 47 |
|
|
2019
Q2 | $32M | Sell |
439,936
-19,500
| -4% | -$1.53M | 0.41% | 50 |
|
|
2019
Q1 | $37M | Buy |
459,436
+99,257
| +28% | +$8.12M | 0.46% | 43 |
|
|
2018
Q4 | $33.2M | Sell |
360,179
-38,800
| -10% | -$3.41M | 0.57% | 32 |
|
|
2018
Q3 | $37.7M | Sell |
398,979
-18,786
| -4% | -$1.78M | 0.56% | 34 |
|
|
2018
Q2 | $38.7M | Sell |
417,765
-33,734
| -7% | -$3.29M | 0.58% | 32 |
|
|
2018
Q1 | $42.7M | Buy |
451,499
+3,714
| +0.8% | +$408K | 0.65% | 28 |
|
|
2017
Q4 | $43.3M | Buy |
447,785
+71,575
| +19% | +$6.75M | 0.66% | 30 |
|
|
2017
Q3 | $33.4M | Buy |
376,210
+14,045
| +4% | +$1.07M | 0.64% | 32 |
|
|
2017
Q2 | $26.3M | Buy |
362,165
+42,632
| +13% | +$2.87M | 0.53% | 37 |
|
|
2017
Q1 | $20.8M | Sell |
319,533
-23,608
| -7% | -$1.48M | 0.5% | 39 |
|
|
2016
Q4 | $21.5M | Sell |
343,141
-31,637
| -8% | -$1.93M | 0.5% | 38 |
|
|
2016
Q3 | $23.6M | Buy |
374,778
+15,522
| +4% | +$1M | 0.52% | 39 |
|
|
2016
Q2 | $22.2M | Sell |
359,256
-12,786
| -3% | -$779K | 0.52% | 40 |
|
|
2016
Q1 | $21.3M | Buy |
372,042
+43,289
| +13% | +$2.41M | 0.49% | 43 |
|
|
2015
Q4 | $19.5M | Sell |
328,753
-17,142
| -5% | -$987K | 0.51% | 40 |
|
|
2015
Q3 | $18.8M | Sell |
345,895
-17,944
| -5% | -$1.17M | 0.52% | 40 |
|
|
2015
Q2 | $24.4M | Buy |
363,839
+4,286
| +1% | +$280K | 0.59% | 35 |
|
|
2015
Q1 | $21M | Sell |
359,553
-19,463
| -5% | -$1.18M | 0.48% | 47 |
|
|
2014
Q4 | $24.8M | Sell |
379,016
-26,105
| -6% | -$1.65M | 0.54% | 36 |
|
|
2014
Q3 | $23.4M | Sell |
405,121
-32,113
| -7% | -$1.78M | 0.5% | 38 |
|
|
2014
Q2 | $24.7M | Sell |
437,234
-24,308
| -5% | -$1.28M | 0.49% | 39 |
|
|
2014
Q1 | $23.7M | Buy |
461,542
+20,303
| +5% | +$1.03M | 0.47% | 43 |
|
|
2013
Q4 | $23.3M | Sell |
441,239
-25,624
| -5% | -$1.26M | 0.49% | 43 |
|
|
2013
Q3 | $20.9M | Sell |
466,863
-34,721
| -7% | -$1.54M | 0.45% | 46 |
|
|
2013
Q2 | $20.7M | Buy |
+501,584
| New | +$21.9M | 0.43% | 49 |
|
Other funds holding ABBV
ECSS
ATO
Fjarde Ap-fonden's ABBV Position: Q2 2026 in Review
Fjarde Ap-fonden increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $2.22M and bringing the position to 543,225 shares worth $137M. The position accounts for 0.65% of the portfolio, ranked #30.
Fjarde Ap-fonden first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Fjarde Ap-fonden held 543,225 shares of AbbVie worth $137M as of Q2 2026.
- Fjarde Ap-fonden bought 10,300 AbbVie shares in Q2 2026, an estimated $2.22M.
- AbbVie made up 0.65% of Fjarde Ap-fonden's portfolio in Q2 2026, its #30 holding.
- Fjarde Ap-fonden first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.